Leonurine protects against tumor necrosis factor-α-mediated inflammation in human umbilical vein endothelial cells

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 34-42

  Liu, Xinhua ^a   Pan, Lilong ^a   Wang, Xianli ^a   Gong, Qihai ^a   Zhu, Yi Zhun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Adhesion molecules; Atherosclerosis; Cyclooxygenase 2; Human umbilical vein endothelial cells; Inflammation; Leonurine; Reactive oxygen species

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LEONURINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY ENDOTHELIUM; ARTICLE; CELL ADHESION; CELL NUCLEUS; CELL PROTECTION; CELL STRAIN U937; CONCENTRATION RESPONSE; DNA BINDING; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATION; MEDIATOR; MICROSCOPE; MONOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

CELL ADHESION; CHEMOKINE CCL2; CYCLOOXYGENASE 2; GALLIC ACID; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; I-KAPPA B KINASE; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84862822228     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.04.027     Document Type: Article

References (20)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
3. Hernández-Presa M.A., Martín-Ventura J.L., Ortego M., et al. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. Atherosclerosis 2002, 160:49-58.
4. Sprague A.H., Khalil R.A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009, 78:539-552.
5. Sperone A., Dryden N.H., Birdsey G.M., et al. The transcription factor Erg inhibits vascular inflammation by repressing NF-kappaB activation and proinflammatory gene expression in endothelial cells. Arterioscler Thromb Vasc Biol 2011, 31:142-150.
6. Hulsmans M., Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med 2010, 14:70-78.
7. Sury M.D., Frese-Schaper M., Mühlemann M.K., et al. Evidence that N-acetylcysteine inhibits TNF-alpha-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase. Free Radic Biol Med 2006, 41:1372-1383.
8. Yang W.S., Lee J.M., Han N.J., et al. Mycophenolic acid attenuates tumor necrosis factor-alpha-induced endothelin-1 production in human aortic endothelial cells. Atherosclerosis 2010, 211:48-54.
9. Liu X.H., Xin H., Zhu Y.Z. More than a mother-benefiting herb: cardioprotective effect of Herba leonuri. Sheng Li Xue Bao 2007, 59:578-584.
10. Sun J., Huang S.H., Zhu Y.C., et al. Anti-oxidative stress effects of Herba leonuri on ischemic rat hearts. Life Sci 2005, 76:3043-3056.
11. 2O-extract from an Oriental medicinal plant Leonuri herba. Jpn J Pharmacol 2001, 86:215-222.
12. Liu X.H., Pan L.L., Gong Q.H., et al. Antiapoptotic effect of novel compound from Herba leonuri-leonurine (SCM-198): a mechanism through inhibition of mitochondria dysfunction in H9c2 cells. Curr Pharm Biotechnol 2010, 11:895-905.
13. Liu X.H., Pan L.L., Gong Q.H., et al. Leonurine (SCM-198) improves cardiac recovery in rat during chronic infarction. Eur J Pharmacol 2010, 649:236-241.
14. Simoncini T., Maffei S., Basta G., et al. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res 2000, 87:19-25.
15. Viatour P., Merville M.P., Bours V., Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005, 30:43-52.
16. Collins T., Cybulsky M.I. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?. J Clin Invest 2001, 107:255-264.
17. Brasier A.R. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 2010, 86:211-218.
18. Hu J., Nakano H., Sakurai H., Colburn N.H. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells. Carcinogenesis 2004, 25:1991-2003.
19. Mattioli I., Sebald A., Bucher C., et al. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. J Immunol 2004, 172:6336-6344.
20. Kim S.R., Bae Y.H., Bae S.K., et al. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 2008, 1783:886-895.